Rita J Desai

Array ( [id] => 8815185 [patent_doc_number] => 20130116229 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-09 [patent_title] => 'NOVEL INHIBITOR COMPOUNDS OF PHOSPHODIESTERASE TYPE 10A' [patent_app_type] => utility [patent_app_number] => 13/672438 [patent_app_country] => US [patent_app_date] => 2012-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 66815 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13672438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8822185 [patent_doc_number] => 20130123230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-16 [patent_title] => '2-Thiopyrimidinones' [patent_app_type] => utility [patent_app_number] => 13/670852 [patent_app_country] => US [patent_app_date] => 2012-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 70848 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13670852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9670383 [patent_doc_number] => 20140234245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-21 [patent_title] => 'N-(PYRID-4-YL)AMIDES AND N-(PYRIMIDIN-4-YL)AMIDES AND THEIR PHARMACEUTICAL AND COSMETIC USE' [patent_app_type] => utility [patent_app_number] => 14/355810 [patent_app_country] => US [patent_app_date] => 2012-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26362 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14355810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11230941 [patent_doc_number] => 09458161 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2016-10-04 [patent_title] => 'TSPO ligands for cancer imaging and treatment' [patent_app_type] => utility [patent_app_number] => 13/669437 [patent_app_country] => US [patent_app_date] => 2012-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 30 [patent_no_of_words] => 28445 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13669437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10522657 [patent_doc_number] => 09249154 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-02 [patent_title] => 'Compounds and therapeutic use thereof for protein kinase inhibition' [patent_app_type] => utility [patent_app_number] => 13/668197 [patent_app_country] => US [patent_app_date] => 2012-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8224 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13668197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8721270 [patent_doc_number] => 20130072487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-21 [patent_title] => 'PROLYL HYDROXYLASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/667634 [patent_app_country] => US [patent_app_date] => 2012-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48324 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13667634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9721056 [patent_doc_number] => 20140256756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-11 [patent_title] => 'PIPERIDINYL-SUBSTITUTED LACTAMS AS GPR119 MODULATORS' [patent_app_type] => utility [patent_app_number] => 14/355804 [patent_app_country] => US [patent_app_date] => 2012-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40521 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14355804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9721058 [patent_doc_number] => 20140256759 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-11 [patent_title] => 'KINASE INHIBITOR AND METHOD FOR TREATMENT OF RELATED DISEASES' [patent_app_type] => utility [patent_app_number] => 14/354302 [patent_app_country] => US [patent_app_date] => 2012-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10680 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14354302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10587601 [patent_doc_number] => 09309203 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-12 [patent_title] => 'Malignant and non-malignant disease treatment with Ras antagonists' [patent_app_type] => utility [patent_app_number] => 14/350303 [patent_app_country] => US [patent_app_date] => 2012-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 10351 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14350303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9699448 [patent_doc_number] => 20140249133 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-04 [patent_title] => 'SUBSTITUTED BENZYLINDAZOLES FOR USE AS BUB1 KINASE INHIBITORS IN THE TREATMENT OF HYPERPROLIFERATIVE DISEASES' [patent_app_type] => utility [patent_app_number] => 14/350160 [patent_app_country] => US [patent_app_date] => 2012-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 75773 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14350160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9699469 [patent_doc_number] => 20140249154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-04 [patent_title] => 'SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF CANCERS, INCLUDING HEPATOCELLULAR CARCINOMA, AND AS INHIBITORS OF HEPATITIS VIRUS REPLICATION' [patent_app_type] => utility [patent_app_number] => 14/349014 [patent_app_country] => US [patent_app_date] => 2012-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20905 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14349014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9720978 [patent_doc_number] => 20140256677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-11 [patent_title] => 'HETEROCYCLYLPYRI (MI) DINYLPYRAZOLE AS FUNGICIDALS' [patent_app_type] => utility [patent_app_number] => 14/349144 [patent_app_country] => US [patent_app_date] => 2012-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63647 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14349144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9699484 [patent_doc_number] => 20140249169 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-04 [patent_title] => '1-PYRAZOLYL-3- (4- ((2 -ANILINOPYRIMIDIN- 4 - YL) OXY) NAPTHTHALEN- 1- YL) UREAS AS P38 MAP KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 14/349345 [patent_app_country] => US [patent_app_date] => 2012-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16888 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14349345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9699449 [patent_doc_number] => 20140249134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-04 [patent_title] => 'TRIAZOLYL PDE10 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 14/349030 [patent_app_country] => US [patent_app_date] => 2012-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34488 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14349030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9869295 [patent_doc_number] => 08957068 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-17 [patent_title] => '3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH' [patent_app_type] => utility [patent_app_number] => 14/347481 [patent_app_country] => US [patent_app_date] => 2012-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 123028 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14347481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9626632 [patent_doc_number] => 08796312 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-05 [patent_title] => 'Heteroaryl derivatives as CFTR modulators' [patent_app_type] => utility [patent_app_number] => 13/627222 [patent_app_country] => US [patent_app_date] => 2012-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23100 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13627222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8638368 [patent_doc_number] => 20130030171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-31 [patent_title] => 'Pyrimidinyl Aryl Urea Derivatives being FGF Inhibitors' [patent_app_type] => utility [patent_app_number] => 13/624320 [patent_app_country] => US [patent_app_date] => 2012-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35922 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13624320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10946951 [patent_doc_number] => 20140349972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-27 [patent_title] => 'SUBSTITUTED PYRIMIDINES' [patent_app_type] => utility [patent_app_number] => 14/346513 [patent_app_country] => US [patent_app_date] => 2012-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47241 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14346513 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9989647 [patent_doc_number] => 09034851 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-19 [patent_title] => 'Substituted pyrimidines' [patent_app_type] => utility [patent_app_number] => 14/346522 [patent_app_country] => US [patent_app_date] => 2012-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20798 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14346522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10070584 [patent_doc_number] => 09108926 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-18 [patent_title] => 'Disubstituted 5-fluoro-pyrimidines' [patent_app_type] => utility [patent_app_number] => 14/343983 [patent_app_country] => US [patent_app_date] => 2012-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33821 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14343983 [rel_patent_id] =>[rel_patent_doc_number] =>)